samsung Archives - Medical Design Sourcing

Samsung partners with Lunit on AI for enhanced chest screenings

[Image courtesy of Samsung/Lunit]Samsung announced today that it entered into a supply contract with Lunit to utilize its AI-powered solutions for chest screenings.

Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound business, inked the deal. Lunit offers AI technology for cancer diagnostics and therapeutic. Together, they aim to enable faster and more accurate chest screenings for timely interventions with improved patient outcomes.

The companies plan to combine Lunit’s Insight CXR and Insight CXR Triage with Samsung’s computer-aided detection (CAD) AI. Lunit’s chest X-ray analysis technology and FDA-cleared AI triage solution enable the CAD AI to help radiologists manage patient exams by prioritizing those with suspected abnormalities.

Samsung Head of Digital Radiography, Eric Sumner, said chest X-rays are the “most requested exam in radiography.”

By partnering with Lunit, our Sa…

Samsung could battle Apple over non-invasive glucose monitors

A stock photo of the Galaxy Watch. [Image courtesy of Samsung]Bloomberg reports that Samsung has eyes on developing non-invasive glucose monitoring technology, potentially pitting it against Apple.

The report says the electronics company wants to develop continuous blood pressure checking along with glucose monitoring. It comes as part of an effort to incorporate health features in Samsung devices, like its Galaxy Ring, Bloomberg says. Hon Pak, a Samsung executive in charge of this push, told the outlet in an interview that the company is putting “significant investment” toward these new functions.

According to Bloomberg, Samsung is considering several possible avenues for this technology, including miniaturization. Pak expects to see non-invasive glucose monitoring hit the market in some form within five years, the outlet said.

While the report has no projected timeline for the Samsung project itself, if and when it moves forward, it will likel…

Samsung spinoff Wellysis wins FDA nod for wearable ECG

The S-Patch Ex wearable ECG system. [Image courtesy of Wellysis]Competition in the wearable ECG space continues to heat up, with Samsung spinoff Wellysis as the latest U.S. market entrant.

Seoul, South Korea–based Wellysis announced today that it has secured FDA clearance for its S-Patch Ex. The device already has a CE Mark, with Wellysis marketing the S-Patch Ex in 14 countries. Its markets include the U.K., Spain, Italy, Greece, Poland, Australia, Thailand, India, and Korea.

Wellysis plans a U.S. launch this month by establishing partnerships with service and platform providers.

The company sees uses for the ECG and heart rate recording device in both home and clinical settings. Samsung Electronics’ next-generation bio-processor, embedded in the S-Patch Ex, ensures accurate ECG waveforms, according to Wellysis.

“We are excited to introduce its outstanding features to the U.S. market base with the FDA clearance in the U.S.,” Wellys…

HeartBeam partners with Samsung to boost at-home cardiac care

HeartBeam has announced a strategic alliance agreement (SAA) with global tech giant Samsung.

The alliance, announced today, builds upon an existing SAA between Samsung and Livmor, whose assets HeartBeam acquired earlier this year.

Livmor created the FDA-cleared wearable Halo atrial fibrillation detection system — an FDA-cleared, Samsung-Galaxy-watch-based arrhythmia detection tool. Meanwhile, HeartBeam recently secured a pivotal patent related to artificial intelligence capabilities for its AIMIGo system — a personal, portable vector electrocardiogram (VECG) system. Also, this month, HeartBeam submitted AIMIGo for FDA 510(k) clearance.

This collaborative venture between HeartBeam and Samsung will explore opportunities to leverage HeartBeam’s proprietary technology and expertise in cardiac symptom assessment and monitoring. The two companies think their technologies could boost the standard of cardiac diagnostic capabilities.

HeartBeam’…

Samsung, HealthTap partner to bring virtual care to Smart TVs

HealthTap announced a strategic partnership with Samsung to bring virtual healthcare directly to Samsung’s Smart TVs in the U.S.

The strategic partnership brings a telehealth solution to Samsung Smart TV users’ fingertips. HealthTap offers access to healthcare via its mobile and desktop applications, with the new capabilities highlighting a step forward for its platform.

Palo Alto, California-based HealthTap said in a news release that it particularly benefits the senior population, which comprises one of Samsung’s largest purchaser segments. In addition, the company said it aligns with its mission to provide quality, affordable primary care at every American’s fingertips. It aims to do so for anyone, regardless of whether they have good insurance coverage or benefits.

“Developing a primary care relationship is critical for all Americans, and the ability to conveniently access telemedicine through a TV screen empowers everyone to …

Samsung unveils new V7 ultrasound system

The Samsung V7 ultrasound system [Image courtesy of Samsung]Samsung today introduced its V7 ultrasound system, having recently picked up FDA 510(k) clearance for commercial use.

Danvers, Massachusetts–based Boston Imaging — the U.S. headquarters of Samsung’s digital radiography and ultrasound business — unveiled the platform. It designed the ultrasound system to provide a range of clinical applications, improving the patient and user experience.

“There is a continued demand on imaging professionals to deliver high-quality results in an efficient amount of time, without compromising patient care,” said David Legg, VP, Head of Boston Imaging. “We’re proud to help address this by supplying one more solution that helps make clinical assessments effortless and treatment precise.”

V7 includes enhanced image clarity through Samsung Crystal Architecture. It features the combination of CrystalBeam beamforming, CrystalLive image processing and S-Vue Single Crys…

EchoNous partners with Samsung on AI-guided ultrasound

EchoNous’ Kosmos ultrasound device [Image courtesy of EchoNous]EchoNous announced today that it entered into an alliance with Samsung to run its ultrasound offerings off the Galaxy mobile tablets.

Redmond, Washington-based EchoNous develops the Kosmos portable, artificial intelligence (AI)-guided point-of-care ultrasound (POCUS) tool. Under the new partnership, Kosmos will now be able to run on off-the-shelf Samsung Galaxy Tab Active Pro tablets (models 12.0 and higher).

According to a news release, the new compatibility will lower the overall price point of the Kosmos platform, which EchoNous said already costs “tens of thousands of dollars less” than the cart-based models against which it competes. The compatibility is aided by Samsung’s Active Pro tablet’s speed, power and battery life, the company said.

“Even for the largest medical providers in the world, every dollar saved is one that can be spent s…

Texas power grid struggles a year after cold stopped semiconductor plants

Samsung workers at a semiconductor fabrication plant [Photo courtesy of Samsung]A heat wave in Texas took at least six power plants offline Friday with high temperatures forecasted to blaze throughout this week.

A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production.

There’s no indication yet that the power grid’s latest struggles will reduce or stop semiconductor production, but the Electric Reliability Council of Texas (ERCOT) has asked residents to curb their electricity use ahead of more heat.

“With unseasonably hot weather driving record demand across Texas, ERCOT continues to work closely with the power industry to make sure Texans have the power they need,” ERCOT Interim CEO Brad Jones said in a news release.

Get the full story at…

Texas power grid struggles in heat one year after record cold stopped semiconductor plants

Samsung workers at a semiconductor fabrication plant [Photo courtesy of Samsung]

A heat wave in Texas took at least six power plants offline Friday with high temperatures forecasted to blaze throughout this week.

A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production.

There’s no indication yet that the power grid’s latest struggles will reduce or stop semiconductor production, but the Electric Reliability Council of Texas (ERCOT) has asked residents to curb their electricity use ahead of more heat.

“With unseasonably hot weather driving record demand across Texas, ERCOT continues to work closely with the power industry to make sure Texans have the power they need,” ERCOT Interim CEO Brad Jones said in a news relea…

Microsoft CMO: Using the cloud to improve medtech design, manufacturing and care

Dr. David Rhew is Microsoft’s global chief medical officer and VP of healthcare. [Photo courtesy of Microsoft]Dr. David Rhew, Microsoft’s global chief medical officer and VP of healthcare, has been studying how technology can improve health outcomes for nearly three decades.

His focus has long been on access to care, quality of care, patient safety, improving experiences for patients and providers, and finding ways to improve the overall efficiency of care.

He was previously CMO at Samsung and Zynx Health before that. But his role at Redmond, Washington-based Microsoft (NSDQ:MSFT) — one of the world’s cloud-computing leaders — offers his best opportunity yet to shape the future of medtech.

Rhew spoke with Medical Design & Outsourcing as part of an ongoing series of conversations about cloud computing’s contributions to medtech and the potential ahead.

Get the full story at Medical Design & Outsourcing.

Microsoft CMO: Using the cloud to improve medtech design, manufacturing and care

David Rhew is Microsoft’s global chief medical officer and VP of healthcare. [Photo courtesy of Microsoft]

Dr. David Rhew, Microsoft’s global chief medical officer and VP of healthcare, has been studying how technology can improve health outcomes for nearly three decades.

His focus has long been on access to care, quality of care, patient safety, improving experiences for patients and providers, and finding ways to improve the overall efficiency of care.

He was previously CMO at Samsung and Zynx Health before that. But his role at Redmond, Washington-based Microsoft (NSDQ:MSFT) — one of the world’s cloud-computing leaders — offers his best opportunity yet to shape the future of medtech.

Rhew spoke with Medical Design & Outsourcing as part of an ongoing series of conversations about cloud computing’s contributions to medtech and the potential ahead. The discussion that f…